公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006 | Hsu M.-S.; Liao C.-H.; YU-TSUNG HUANG ; Liu C.-Y.; Yang C.-J.; Kao K.-L.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 85 | 85 | |
2005 | Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever | Jun H.X.; Zhixiang S.; Chun W.; Reksodiputro A.H.; Ranuhardy D.; Tamura K.; Matsumoto T.; Lee D.-G.; Purushotaman S.V.; Lim V.; Ahmed A.; Hussain Y.; Chua M.; Ong A.; Liu C.-Y.; PO-REN HSUEH ; Lin S.-F.; Liu Y.-C.; Suwangool P.; Jootar S.; Picazo J.J. | International Journal of Antimicrobial Agents | 26 | 14 | |
2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
2010 | Clinical result of sintered bovine hydroxyapatite bone substitute: Analysis of the interface reaction between tissue and bone substitute | Tsai W.-C.; Liao C.-J.; CHEN-TU WU ; Liu C.-Y.; Lin S.-C.; Tai-Horng Young ; Wu S.-S.; Liu H.-C. | Journal of Orthopaedic Science | 15 | 11 | |
2008 | Clinical significance of Blastocystis hominis: Experience from a medical center in northern Taiwan | HAN-YUEH KUO ; Chiang D.-H.; Wang C.-C.; Chen T.-L.; Fung C.-P.; Lin C.-P.; Cho W.-L.; Liu C.-Y. | Journal of Microbiology, Immunology and Infection | 18 | 12 | |
2017 | Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia | HSIN-AN HOU ; Lu J.-W.; Lin T.-Y.; CHENG-HONG TSAI ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; YUAN-YEH KUO ; Liu C.-Y.; Tseng M.-H.; Chiang Y.-C.; Peng Y.-L.; JIH-LUH TANG ; Gong Z.; LIANG-IN LIN ; HWEI-FANG TIEN | Blood cancer journal | 15 | | |
2017 | Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells | Liu C.-Y.; Lau K.-Y.; Hsu C.-C.; Chen J.-L.; Lee C.-H.; Huang T.-T.; Chen Y.-T.; Huang C.-T.; PO-HAN LIN ; Tseng L.-M. | PLoS ONE | 45 | 40 | |
2016 | Comorbid psychiatric diagnosis and psychological correlates of eating disorders in dance students | Liu C.-Y.; Tseng M.-C.M.; Chang C.-H.; Fang D.; MING-BEEN LEE | Journal of the Formosan Medical Association | 19 | 16 | |
2017 | Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas | Gow C.-H.; Chang H.-T.; Lim C.-K.; Liu C.-Y.; JIN-SHING CHEN ; JIN-YUAN SHIH | Genes Chromosomes and Cancer | 15 | 15 | |
2010 | Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma | Hsieh C.-H.; Liu C.-Y.; Shueng P.-W.; Chong N.-S.; Chen C.-J.; Chen M.-J.; Lin C.-C.; Wang T.-E.; Lin S.-C.; Tai H.-C.; Tien H.-J.; Chen K.-H.; LI-YING WANG ; Hsieh Y.-P.; Huang D.Y.C.; Chen Y.-J. | Radiation Oncology | 35 | 30 | |
2006 | Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan | Lau Y.-J.; PO-REN HSUEH ; Liu Y.-C.; Shyr J.-M.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y.; KWEN-TAY LUH | Microbial Drug Resistance | 32 | 28 | |
2011 | Consensus statement on the role of fluoroquinolones in the management of urinary tract infections | PO-REN HSUEH ; Lau Y.-J.; Ko W.-C.; Liu C.-Y.; Huang C.-T.; Yen M.-Y.; Liu Y.-C.; Lee W.-S.; Liao C.-H.; Peng M.-Y.; Chen C.-M.; Chen Y.-S. | Journal of Microbiology, Immunology and Infection | 10 | 10 | |
2018 | Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023)) | Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN ; Kim I.; Shiau C.-W. | European Journal of Medicinal Chemistry | 1 | 1 | |
2017 | Corrigendum to “Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009” [Diagn Microbiol Infect Dis 2015;81(4):290–295] (S0732889314004076)(10.1016/j.diagmicrobio.2014.09.027) | Jean S.-S.; Lee W.-S.; Bai K.-J.; Yu K.-W.; Hsu C.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Chen R.-J.; PO-REN HSUEH | Diagnostic Microbiology and Infectious Disease | 0 | 0 | |
2018 | Corrigendum to “Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)” [J Microbiol Immunol Infect 49 (2016) 969–976] (S1684118215000213) (10.1016/j.jmii.2014.12.008)) | Jean S.-S.; Lee W.-S.; Yu K.-W.; Liao C.-H.; Hsu C.-W.; Chang F.-Y.; Ko W.-C.; Chen R.-J.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Lam C.; Liu C.-Y.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 4 | 2 | |
2010 | Cost minimisation analysis of antimicrobial treatment for intra-abdominal infections: a multicentre retrospective study from Taiwan | PO-REN HSUEH ; Liu C.-Y.; Shi Z.-Y.; Lee M.-H.; Chang F.-Y.; Yang M.-C. | International Journal of Antimicrobial Agents | 2 | 2 | |
2002 | Current status of antimicrobial resistance in Taiwan | PO-REN HSUEH ; Liu C.-Y.; KWEN-TAY LUH | Emerging Infectious Diseases | 147 | 124 | |
2013 | CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions | Kuo H.-W.; Liu S.C.; Tsou H.-H.; Liu S.-W.; Lin K.-M.; SHAO-CHUN LU ; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Chen C.-H.; Lu M.-L.; Shen W.W.; Tang H.-S.; Liu S.-I.; Chang L.-H.; Wu H.-Y.; Chang Y.-S.; Yeh T.-K.; Chen A.C.; Liu Y.-L. | Pharmacogenomics | 21 | 16 | |
2010 | CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine | Lin K.-M.; Tsou H.-H.; Tsai I.-J.; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Shen W.W.; Tang H.-S.; Fang C.-K.; CHI-SHIN WU ; SHAO-CHUN LU ; Kuo H.-W.; Liu S.C.; Chan H.-W.; Hsu Y.-T.; Tian J.-N.; Liu Y.-L. | Pharmacogenomics | 36 | 32 | |
2019 | Daily activity, mood, and quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy: A mediation effect analysis | LING-CHUN LU ; Tsay S.-L.; Chang S.-Y.; Chen C.-M.; Liu C.-Y. | Cancer Medicine | 15 | 15 | |